TBX2 and posterior cortical atrophy: In summary, our study reveals a crucial signaling axis downstream of TBX2 that drives the NEPC pathophysiology including exosome-mediated transfer, and our findings could provide critical clues in understanding the molecular/signaling events that drive and propagate therapy resistance in this lethal subset of advanced PCa.